A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases
Y Fan,
M Arechederra,
S Richelme,
F Daian,
C Novello,
Julien CALDERARO,
L Di Tommaso,
G Morcrette,
S Rebouissou,
M Donadon,
E Morenghi,
J Zucman-Rossi,
M Roncalli,
R Dono,
F Maina,
Hepatology 01/11/2017;66(5) : 1644-1661 10.1002/hep.29304 29/09/2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
V Vilgrain,
H Pereira,
E Assenat,
B Guiu,
AD Ilonca,
GP Pageaux,
A Sibert,
M Bouattour,
R Lebtahi,
W Allaham,
H Barraud,
V Laurent,
E Mathias,
JP Bronowicki,
JP Tasu,
R Perdrisot,
C Silvain,
R Gerolami,
O Mundler,
JF Seitz,
X Vidal,
C Aubé,
F Oberti,
O Couturier,
I Brenot-Rossi,
JL Raoul,
A Sarran,
C Costentin,
E Itti,
Alain LUCIANI,
R Adam,
M Lewin,
D Samuel,
M Ronot,
A Dinut,
L Castera,
G Chatellier,
SARAH Trial Group.
Lancet Oncol. 26/10/2017;pii: S1470-2045(17) : 30683-6 10.1016/S1470-2045(17)30683-6.
Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma
C Lim,
P Bhangui,
C Salloum,
C Gomez Gavara,
E Lahat,
Alain LUCIANI,
P Compagnon,
Julien CALDERARO,
Cyrille FERAY,
D Azoulay,
J Hepatol. 06/10/2017;pii: S0168-8278(17) : 32331-0 10.1016/j.jhep.2017.09.017
Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell Lymphoma
AS Cottereau,
S Mule,
C Lin,
K Belhadj,
A Vignaud,
C Copie-Bergman,
A Boyez,
P Zerbib,
Vania TACHER,
E Scherman,
C Hajoun,
Alain LUCIANI,
E Itti,
A Rahmouni,
Radiology 06/10/2017;170599 : . 10.1148/radiol.2017170599.
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien CALDERARO,
G Couchy,
S Imbeaud,
Giuliana AMADDEO,
E Letouze,
JF Blanc,
C Laurent,
Y Hajji,
D Azoulay,
P Bioulac-Sage,
JC Nault,
J Zucman-Rossi,
J Hepatol. 01/10/2017;67(4) : 727-738 10.1016/j.jhep.2017.05.014. 19/05/2017
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
MP Carrieri,
C Protopopescu,
Z Younossi,
A Vilotitch,
H Fontaine,
V Petrov-Sanchez,
F Marcellin,
F Carrat,
Christophe HEZODE,
M Bourliere,
Patient. 01/10/2017;10(5) : 605-614 10.1007/s40271-017-0232-1.
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3
F Artru,
A Louvet,
Isaac RUIZ,
E Levesque,
J Labreuche,
J Ursic-Bedoya,
G Lassailly,
S Dharancy,
E Boleslawski,
G Lebuffe,
E Kipnis,
P Ichai,
A Coilly,
E De Martin,
TM Antonini,
E Vibert,
S Jaber,
A Herrerro,
D Samuel,
A Duhamel,
GP Pageaux,
P Mathurin,
F Saliba,
J Hepatol. 01/10/2017;67(4) : 708-715 10.1016/j.jhep.2017.06.009 21/07/2017
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
A Vienot,
G Beinse,
A Louvet,
L de Mestier,
A Meurisse,
F Fein,
B Heyd,
D Cleau,
C d'Engremont,
AC Dupont-Gossart,
Z Lakkis,
C Tournigand,
O Bouché,
Benoit ROUSSEAU,
C Neuzillet,
F Bonnetain,
C Borg,
D Vernerey,
J Natl Cancer Inst. 01/10/2017;109(10) : . 10.1093/jnci/djx037.
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
T Asselah,
KV Kowdley,
N Zadeikis,
S Wang,
T Hassanein,
Y Horsmans,
M Colombo,
F Calinas,
H Aguilar,
V De Ledinghen,
PS Mantry,
Christophe HEZODE,
RT Marinho,
K Agarwal,
F Nevens,
M ElKhashab,
J Kort,
R Liu,
TI Ng,
P Krishnan,
CW Lin,
FJ Mensa,
Clin Gastroenterol Hepatol. 22/09/2017;pii: S1542-3565(17) : 31162-X 10.1016/j.cgh.2017.09.027.
